Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
160 hedge funds and large institutions have $2.2B invested in Portola Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 71 increasing their positions, 44 reducing their positions, and 24 closing their positions.
1,619% more call options, than puts
Call options by funds: $3.95M | Put options by funds: $230K
61% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 44
21% more capital invested
Capital invested by funds: $1.82B → $2.2B (+$388M)
0% more funds holding
Funds holding: 160 → 160 (0)
0% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 24
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.9M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$14.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.2M |
| 5 |
GH
GAM Holding
Zurich,
Switzerland
|
+$7.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$37.2M |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$13.2M |
| 3 |
Millennium Management
New York
|
-$11.6M |
| 4 |
DM
Deerfield Management
New York
|
-$9.84M |
| 5 |
PA
Perceptive Advisors
New York
|
-$9.81M |
PTLA Hedge Fund Activity: Q2 2015 in Review
160 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q2 2015, worth a combined $2.2B — up 21% from $1.82B a quarter earlier.
Fund positioning in PTLA was balanced in Q2 2015: 24 funds opened new positions, 24 closed out, 71 added to existing stakes and 44 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $30.8M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $37.2M sold.
- 160 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $2.2B of Portola Pharmaceuticals, Inc. stock for Q2 2015, up 21% quarter-over-quarter.
- 24 funds opened new Portola Pharmaceuticals, Inc. positions in Q2 2015 and 24 closed out, a net change of 0 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q2 2015 was Wellington Management Group, an estimated $30.8M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q2 2015 was Scopia Capital Management, an estimated $37.2M sold.
Based on aggregated 13F filings for Q2 2015.